Tags

Type your tag names separated by a space and hit enter

Medical management of nocturnal enuresis.
Paediatr Drugs. 2012 Apr 01; 14(2):71-7.PD

Abstract

Nocturnal enuresis, or bedwetting, is the most common cause of urinary incontinence in children. It is known to have a significant psychosocial impact on the child as well as the family. Nocturnal enuresis typically presents as failure to become dry at night after successful daytime toilet training. It can be primary or secondary (developing after being successfully dry at night for at least 6 months). Children with nocturnal enuresis may have excessive nocturnal urine production, poor sleep arousal and/or reduced bladder capacity. Alarm therapy is the recommended first-line therapy, with treatment choices being influenced by the presence or absence of the abnormalities mentioned above. Children with nocturnal enuresis may also have daytime urinary urgency, frequency or incontinence of urine. This group (non-monosymptomatic nocturnal enuresis) requires a different clinical approach, with a focus on treating daytime bladder symptoms, which commonly involves pharmacotherapy with anticholinergic medications and urotherapy (including addressing bowel problems). This review discusses the current management of nocturnal enuresis using the terminologies recommended by the International Children's Continence Society.

Authors+Show Affiliations

Department of Urology, The Childrens Hospital at Westmead, Westmead, NSW, Australia.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22168597

Citation

Deshpande, Aniruddh V., and Patrina H Y. Caldwell. "Medical Management of Nocturnal Enuresis." Paediatric Drugs, vol. 14, no. 2, 2012, pp. 71-7.
Deshpande AV, Caldwell PH. Medical management of nocturnal enuresis. Paediatr Drugs. 2012;14(2):71-7.
Deshpande, A. V., & Caldwell, P. H. (2012). Medical management of nocturnal enuresis. Paediatric Drugs, 14(2), 71-7. https://doi.org/10.2165/11594870-000000000-00000
Deshpande AV, Caldwell PH. Medical Management of Nocturnal Enuresis. Paediatr Drugs. 2012 Apr 1;14(2):71-7. PubMed PMID: 22168597.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Medical management of nocturnal enuresis. AU - Deshpande,Aniruddh V, AU - Caldwell,Patrina H Y, PY - 2011/12/16/entrez PY - 2011/12/16/pubmed PY - 2013/3/30/medline SP - 71 EP - 7 JF - Paediatric drugs JO - Paediatr Drugs VL - 14 IS - 2 N2 - Nocturnal enuresis, or bedwetting, is the most common cause of urinary incontinence in children. It is known to have a significant psychosocial impact on the child as well as the family. Nocturnal enuresis typically presents as failure to become dry at night after successful daytime toilet training. It can be primary or secondary (developing after being successfully dry at night for at least 6 months). Children with nocturnal enuresis may have excessive nocturnal urine production, poor sleep arousal and/or reduced bladder capacity. Alarm therapy is the recommended first-line therapy, with treatment choices being influenced by the presence or absence of the abnormalities mentioned above. Children with nocturnal enuresis may also have daytime urinary urgency, frequency or incontinence of urine. This group (non-monosymptomatic nocturnal enuresis) requires a different clinical approach, with a focus on treating daytime bladder symptoms, which commonly involves pharmacotherapy with anticholinergic medications and urotherapy (including addressing bowel problems). This review discusses the current management of nocturnal enuresis using the terminologies recommended by the International Children's Continence Society. SN - 1179-2019 UR - https://www.unboundmedicine.com/medline/citation/22168597/Medical_management_of_nocturnal_enuresis_ L2 - https://dx.doi.org/10.2165/11594870-000000000-00000 DB - PRIME DP - Unbound Medicine ER -